A2M Proteinuria
A2M Proteinuria
A2M Proteinuria
Index
Introduction
Pathophysiology
Pre-analytical considerations
Analytical considerations
Diagnostic strategy
Data Presentation and Interpretation
Indications and Applications
Figures
Castrocaro 2001 – New Scientific Company – Cormano (MI) – © author 2001 – 2002 – Rev. 17 Page: 1/11
Proteinuria – Diagnostic and Interpratation with Marker Proteins W.H. Siede a, A. Regeniterb
Key Words
Glomerular proteinuria, Tubular proteinuria, Bence Jones Protein, Kappa Free Light Chains, Lambda Free Light
Chains
Castrocaro 2001 – New Scientific Company – Cormano (MI) – © author 2001 – 2002 – Rev. 17 Page: 2/11
Proteinuria – Diagnostic and Interpratation with Marker Proteins W.H. Siede a, A. Regeniterb
Castrocaro 2001 – New Scientific Company – Cormano (MI) – © author 2001 – 2002 – Rev. 17 Page: 3/11
Proteinuria – Diagnostic and Interpratation with Marker Proteins W.H. Siede a, A. Regeniterb
Castrocaro 2001 – New Scientific Company – Cormano (MI) – © author 2001 – 2002 – Rev. 17 Page: 4/11
Proteinuria – Diagnostic and Interpratation with Marker Proteins W.H. Siede a, A. Regeniterb
Castrocaro 2001 – New Scientific Company – Cormano (MI) – © author 2001 – 2002 – Rev. 17 Page: 5/11
Proteinuria – Diagnostic and Interpratation with Marker Proteins W.H. Siede a, A. Regeniterb
complex, manually and in a Hitachi 726 automated 26. Camara NO, Matos AC, Rodrigues DA, Pereira
analyzer. Clin Chem 1986;32:1551-4. AB, Pacheco-Silva A. Early detection of heart
21. Orsonneau JL, Douet P, Massoubre C, transplant patients with increased risk of
Lustenberger P, Bernard S. An improved ciclosporin nephrotoxicity. Lancet 2001;357:856-7.
pyrogallol red-molybdate method for determining 27. Bazzi C, Petrini C, Rizza V, Arrigo G, Beltrame A,
total urinary protein. Clin Chem 1989;35:2233-6. Pisano L, D'Amico G. Urinary excretion of IgG
22. Macart M, Forzy G, Gerbaut L, Vekich AJ, and alpha(1)-microglobulin predicts clinical course
Guilbaud JC. Measuring urinary protein with the better than extent of proteinuria in membranous
new BioRad reagent kit: evaluation and nephropathy. Am J Kidney Dis 2001;38:240-8.
comparison with five other methods. Ann Biol Clin 28. Regeniter A, Siede WH. Determination of free
(Paris) 1994;52:355-60. light chains as screening test for Bence-Jones
23. Boege F, Koehler B, Liebermann F. Identification proteinuria (submitted for publication).
and quantification of Bence-Jones proteinuria by 29. Harrison HH. The „ladder light chain“ or „pseudo-
automated nephelometric screening. J Clin Chem oligoclonal“ pattern in urinary immunofixation
Clin Biochem 1990;28:37-42. electrophoresis (IFE) studies: a distinctive IFE
24. Camara NO, Nishida S, Silva MS, Pestana JO, pattern and an explanatory hypothesis relating it to
Pereira AB, Sesso R, Pacheco-Silva A. Monitoring free polyclonal light chains. Clin Chem
serum beta-2 microglobulin is useful for detecting 1991;37:1559-64.
patients with increased risk of acute rejection 30. MacNamara EM, Aguzzi F, Petrini C, Higginson J,
during reduction in immunosuppression. Gasparro C, Bergami MR, Bianchi G, Whicher JT.
Transplant Proc 1998;30:4158-9. Restricted electrophoretic heterogeneity of
25. Camara NO, Matos AC, Rodrigues DA, Pereira immunoglobulin light chains in urine: a cause for
AB, Pacheco-Silva A. Urinary retinol binding confusion with Bence-Jones protein. Clin Chem
protein is a good marker of progressive 1991;37:1570-4.
cyclosporine nephrotoxicity after heart
transplant. Transplant Proc 2001;33:2129-31.
Castrocaro 2001 – New Scientific Company – Cormano (MI) – © author 2001 – 2002 – Rev. 17 Page: 6/11
Proteinuria – Diagnostic and Interpratation with Marker Proteins W.H. Siede a, A. Regeniterb
Figure 1
X moderately selective
X glomerular
X unselective
X incomplete
X tubular
X complete
X mixed glomerular/tubular
Figure 2
Castrocaro 2001 – New Scientific Company – Cormano (MI) – © author 2001 – 2002 – Rev. 17 Page: 7/11
Proteinuria – Diagnostic and Interpratation with Marker Proteins W.H. Siede a, A. Regeniterb
Figura 3
Differentiation
P Inter-
O pretation P
S Ery ≥ ++ Alb + α1+ IgG R
T Alb≥ 100 mg/g crea TP (> 300 mg/g crea) E
R < 0.3 (0.1) R
E E
N N
A A
L L
α-2- Kappa, Lambda,
Confirmation macroglobulin negative Immunfixation
SDS PAGE
Figure 4
2. Morning Urine
· The second urination in the morning,
approximately 2 hours after the first
Castrocaro 2001 – New Scientific Company – Cormano (MI) – © author 2001 – 2002 – Rev. 17 Page: 8/11
Proteinuria – Diagnostic and Interpratation with Marker Proteins W.H. Siede a, A. Regeniterb
Figure 5
Figure 6
Patterns of Proteinuria
normal tubular incomplete tubular complete
Castrocaro 2001 – New Scientific Company – Cormano (MI) – © author 2001 – 2002 – Rev. 17 Page: 9/11
Proteinuria – Diagnostic and Interpratation with Marker Proteins W.H. Siede a, A. Regeniterb
Figure 7
Figure 8
Followup
Castrocaro 2001 – New Scientific Company – Cormano (MI) – © author 2001 – 2002 – Rev. 17 Page: 10/11
Proteinuria – Diagnostic and Interpratation with Marker Proteins W.H. Siede a, A. Regeniterb
Figure 9
Figure 10
Castrocaro 2001 – New Scientific Company – Cormano (MI) – © author 2001 – 2002 – Rev. 17 Page: 11/11